Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cellular and Molecular Profiling of Tumor Microenvironment and Early-Stage Lung Cancer
Radu Pîrlog, Paul Chiroi, Ioana Rusu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5346-5346
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Lung cancer in never smokers: Tumor immunology and challenges for immunotherapy
Viviane Teixeira Loiola de Alencar, Amanda Braga Figueiredo, Marcelo Corassa, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
Circulating microRNAs for Early Diagnosis of Ovarian Cancer: A Systematic Review and Meta-Analysis
Nanna Lond Skov Frisk, Anja E. Sørensen, Ole Birger Pedersen, et al.
Biomolecules (2023) Vol. 13, Iss. 5, pp. 871-871
Open Access | Times Cited: 13
A Hybrid CNN-Transformer Model for Predicting N Staging and Survival in Non-Small Cell Lung Cancer Patients Based on CT-Scan
Lingling Wang, Chenghao Zhang, Jin Li
Tomography (2024) Vol. 10, Iss. 10, pp. 1676-1693
Open Access | Times Cited: 4
Formation of self-assembly aggregates in traditional Chinese medicine decoctions and their application in cancer treatments
Chunqiu Fang, Yinghang Wang, Zhi Pan
RSC Advances (2025) Vol. 15, Iss. 7, pp. 5476-5506
Open Access
Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC
Julija Šimienė, Daiva Dabkevičienė, Diana Stančiūtė, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Circulating microRNAs in Cancer: A 5-Year Update with a Focus on Breast and Lung Cancers
Dario Siniscalco, Umberto Galderisi, Gianfranco Peluso, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3140-3140
Open Access | Times Cited: 3
Advances in immune checkpoint inhibitors therapy for small cell lung cancer
Longhui Li, Yangyueying Liang, Minghui Yu, et al.
Cancer Medicine (2023) Vol. 12, Iss. 10, pp. 11097-11106
Open Access | Times Cited: 7
Comparing the Efficacy of Two Generations of EGFR-TKIs: An Integrated Drug–Disease Mechanistic Model Approach in EGFR-Mutated Lung Adenocarcinoma
Hippolyte Darré, Perrine Masson, Arnaud Nativel, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 704-704
Open Access | Times Cited: 2
Personalizing Therapy Outcomes through Mitogen-Activated Protein Kinase Pathway Inhibition in Non-Small Cell Lung Cancer
Hasan Alsharoh, Paul Chiroi, Ekaterina Isachesku, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1489-1489
Open Access | Times Cited: 2
Extracellular vesicles from PBDE-47 treated M(LPS) THP-1 macrophages modulate the expression of markers of epithelial integrity, EMT, inflammation and muco-secretion in ALI culture of airway epithelium
Giusy Daniela Albano, Valeria Longo, Angela Marina Montalbano, et al.
Life Sciences (2023) Vol. 322, pp. 121616-121616
Closed Access | Times Cited: 4
A miRNA-disease association prediction model based on tree-path global feature extraction and fully connected artificial neural network with multi-head self-attention mechanism
Hou Biyu, Mengshan Li, Yuxin Hou, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Development of Ex Vivo Analysis for Examining Cell Composition, Immunological Landscape, Tumor and Immune Related Markers in Non-small Cell Lung Cancer
Elena Ufimtseva, Margarita S. Gileva, Ruslan V. Kostenko, et al.
(2024)
Open Access | Times Cited: 1
Immunotherapy for small cell lung cancer: the current state and future trajectories
Min Qiang, Hongyang Liu, Lei Yang, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Decoding the complex web: Cellular and molecular interactions in the lung tumor microenvironment
Bonnie Issa, Ayat Hussein Adhab, Morug Salih Mahdi, et al.
Journal of drug targeting (2024), pp. 1-44
Closed Access | Times Cited: 1
Identification of Potential microRNA Panels for Male Non-Small Cell Lung Cancer Identification Using Microarray Datasets and Bioinformatics Methods
Antonia Haranguș, Lajos Ráduly, Liviuța Budișan, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 12, pp. 2056-2056
Open Access | Times Cited: 6
Role of MicroRNAs in Cancer Development and Treatment
Nikolay Mehterov
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11058-11058
Open Access | Times Cited: 3
Distinct Morphological and Molecular Profiles of NAFLD and NAFLD-associated HCC Revealed by Immunohistochemistry and MicroRNA Analysis
Ioana Rusu, Radu Pîrlog, Paul Chiroi, et al.
Journal of Gastrointestinal and Liver Diseases (2023) Vol. 32, Iss. 3, pp. 356-366
Open Access | Times Cited: 2
Adjusting the dose of traditional drugs combined with immunotherapy: reshaping the immune microenvironment in lung cancer
Linlin Wang, Changqi Du, Bing Jiang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Doxorubicin as a Potential Treatment Option in Canine Mammary Tumors
Luciana-Mădălina Gherman, Oana Zănoagă, Liviuța Budișan, et al.
Veterinary Sciences (2023) Vol. 10, Iss. 11, pp. 654-654
Open Access | Times Cited: 2
Comparing the Efficacy of Two Generations of EGFR-TKIs: An Integrated Drug-Disease Mechanistic Model Approach in Egfr-Mutant Lung Adenocarcinoma
Hippolyte Darré, Perrine Masson, Arnaud Nativel, et al.
(2024)
Open Access
Differential Non-Coding RNA Profiles for Lung Cancer Early Detection in African and White Americans
Lu Gao, Pushpa Dhilipkannah, Van K. Holden, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Next-generation sequencing as a valuable tool for mutational spectrum in advanced-stage NSCLC patients
Ioana Iurca, Ecaterina Isakescu, Laura Pop, et al.
Medicine and Pharmacy Reports (2024) Vol. 97, Iss. 3, pp. 298-307
Open Access
Development of Ex Vivo Analysis for Examining Cell Composition, Immunological Landscape, Tumor and Immune Related Markers in Non-Small-Cell Lung Cancer
Elena Ufimtseva, Margarita S. Gileva, Ruslan V. Kostenko, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2886-2886
Open Access
Immune response, smoking, and lung cancer: a systematic review
V. Yu. Buslaev, A. V. Minin, M. V. Katanakhova, et al.
Fundamental and Clinical Medicine (2024) Vol. 9, Iss. 3, pp. 86-97
Open Access
ANÁLISE DE ESTRATÉGIAS TERAPÊUTICAS PARA O ONCOGENE KRAS EM CÂNCER DE PULMÃO DE CÉLULAS NÃO PEQUENAS
J. F. Silva, THELE ALBUQUERQUE DA SILVA, Walter Luiz Lima Neves, et al.
Revista Foco (2024) Vol. 17, Iss. 12, pp. e7087-e7087
Open Access
Page 1 - Next Page

Scroll to top